Fibrotic Diseases Treatment Market: How Is Cardiac Fibrosis Treatment Emerging as a New Clinical Priority?
The Fibrotic Diseases Treatment Market in 2026 is recognizing cardiac fibrosis — the pathological collagen deposition in myocardial tissue that contributes to diastolic dysfunction, arrhythmia susceptibility, and progressive heart failure in diverse cardiac conditions including heart failure with preserved ejection fraction, atrial fibrillation, hypertensive heart disease, and...
0 Commentarios 0 Acciones 6 Views 0 Vista previa